Da Vinci Research and Outcomes
Meaningful evidence through clinical data and outcomes research
The science behind evidence-based care
Intuitive supports the generation of high-quality clinical evidence through sponsored and collaborative research initiatives. We work with clinicians, hospitals and medical/surgical societies to uncover the benefits of da Vinci technology while maintaining a patients-first mindset and help contribute to the body of knowledge about minimally invasive surgery.
Sponsored and collaborative research includes multicenter studies and key opinion leader partnerships. We also conduct early feasibility studies, product and indication approval studies, post-approval observational outcomes research, clinical registries, and analyses of real-world evidence (RWE) databases. Examining outcomes data helps generate evidence showing value to patients, surgeons, physicians, societies and other key stakeholders.
Our research includes but is not limited to studies across procedures, bariatrics, colorectal, general surgery, gynecology, thoracic, and urology. We also conduct platform specific studies for systems such as da Vinci SP and the Ion endoluminal system.
Maturing clinical evidence
A large-scale systematic literature review and meta-analysis covering the period 2010-2022 is now available for your reading. These results are based on the COMPARE study and recently published in the Annals of Surgery. This meta-analysis of the global literature represents 22 countries, 7 different oncologic procedures including 230 peer-reviewed publications, covering over 1.1 million robotic cases with the da Vinci surgical systems, over 1 million lap/VATS cases and over 1.6 million open cases. This study highlights the clinical value of robotic-assisted surgery using the da Vinci surgical system and will help inform evidence-based decision making by physicians, health care providers, payors and policy makers.
Institutional-driven research with Intuitive support
Working with surgeons, institutions, and societies we help contribute to the body of knowledge about minimally invasive care. Research includes studies and society partnerships.
Ongoing increase in publications
Since 1997, over 44,000+ peer-reviewed publications referencing our technologies have been published in various clinical journals, and the number is growing. They include: randomized studies, systematic reviews, real-world evidence analyses, prospective and retrospective comparison studies, and pre-clinical studies.
Intuitive grant programmes
In addition to a clinical evidence programme, Intuitive has a research and educational grants programme. Our awards support clinical and technology developments and further research in the field of surgical robotics.
Clinical.Affairs.Europe@intusurg.com
https://www.intuitive-foundation.org/fellowships/
Disclosures
Da Vinci 5 Surgical System
The da Vinci 5 Surgical System is intended to assist in the accurate control of da Vinci endoscopes and instruments during minimally invasive endoscopic urologic surgical procedures, gynecologic surgical procedures, general laparoscopic surgical procedures and thoracoscopic surgical procedures. The system is indicated for adult and pediatric use. It is intended to be used by trained physicians in an operating room environment.
The da Vinci 5 Surgical System is a class IIb medical device CE marked (CE 2460) under the European Medical Devices Regulation (EU 2017/745), manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.
Da Vinci X & Xi Surgical Systems
The Intuitive Surgical Endoscopic Instrument Control Systems (da Vinci X and da Vinci Xi Surgical Systems) are intended to assist in the accurate control of Intuitive Surgical Endoscopic Instruments during urologic surgical procedures, general laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general thoracoscopic surgical procedures, and trans-oral otolaryngology surgical procedures restricted to benign tumors and malignant tumors classified as T1 and T2, and for benign base of tongue resection procedures. The systems are indicated for adult and pediatric use (except for trans-oral otolaryngology surgical procedures). They are intended to be used by trained physicians in an operating room environment.
The da Vinci X and da Vinci Xi Surgical Systems are class IIb medical devices CE marked (CE 2460) under the European Medical Devices Directive (93/42/EEC), manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.
Da Vinci SP Surgical System
The da Vinci SP Surgical System is intended to assist in the accurate control of the da Vinci SP endoscope and instruments during minimally invasive endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast surgical procedures. The system is indicated for adult use. It is intended to be used by trained physicians in an operating room environment.
The da Vinci SP Surgical System is a class IIb medical devices CE marked (CE 2460) under the European Medical Devices Regulation (EU 2017/745), manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.
Ion Endoluminal System
The Ion Endoluminal System assists the user in navigating a catheter and endoscopic tools in the pulmonary tract using endoscopic visualization of the tracheobronchial tree for diagnostic and therapeutic procedures. The Ion Endoluminal System enables fiducial marker placement. It does not make a diagnosis and is not for pediatric use.
The Flexision Biopsy Needle is used with the Ion Endoluminal System to biopsy tissue from a target area in the lung.
The PlanPoint Software uses patient CT scans to create a 3D plan of the lung and navigation pathways for use with the Ion Endoluminal System.
The Ion Endoluminal System, the Flexision Biopsy Needle and the PlanPoint Software are class IIa medical devices CE marked (CE 2460) under the European Medical Devices Regulation (EU 2017/745), manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.
SureForm 45 & 60 Staplers
The SureForm 45 Stapler & SureForm 60 Stapler and SureForm 45 Stapler Reloads & SureForm 60 Stapler Reloads and other Stapler Accessories (including the bladeless obturators) are intended to be used with a compatible da Vinci Surgical System for resection, transection, and, or creation of anastomoses in General, Thoracic, Gynecologic, Urologic, and Pediatric surgery. The devices can be used with staple line or tissue buttressing material (natural or synthetic).
The SureForm 60 Stapler and SureForm 45 Stapler, SureForm 60 and SureForm 45 Stapler Reloads are class IIa and IIb medical devices CE marked (CE 2460) under the European Medical Devices Directive (93/42/EEC), manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.
Legal Notices
Individuals' outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or physician/surgeon experience.
Some products, features or technologies may not be available in all countries. Please contact your local Intuitive representative for product availability in your region.
Refer to the product specific User Manual for indications, contraindications, warnings and other product information.